{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T12:43:02Z","timestamp":1768653782823,"version":"3.49.0"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5527-25","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:07:32Z","timestamp":1750270052000},"page":"337-342","source":"Crossref","is-referenced-by-count":0,"title":["Secondary Membranous Nephropathy Associated with &lt;i&gt;Mycobacterium intracellulare&lt;\/i&gt;"],"prefix":"10.2169","volume":"65","author":[{"given":"Masaru","family":"Ando","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honoka","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Yamatani","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Omote","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Suenaga","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Oita Prefectural Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Katafuchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Komiya","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infection Diseases, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yuan Q, Sun L, Feng J, et al. Lumbar tuberculosis associated with membranous nephropathy and interstitial nephritis. J Clin Microbiol 48: 2303-2306, 2010.","DOI":"10.1128\/JCM.02302-09"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ram R, Swarnalatha G, Desai M, et al. Membranous nephropathy and granulomatous interstitial nephritis due to tuberculosis. Clin Nephrol 76: 487-491, 2011.","DOI":"10.5414\/CN106678"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kanaji N, Kushida Y, Bandoh S, et al. Membranous glomerulonephritis associated with <i>Mycobacterium shimoidei<\/i> pulmonary infection. Am J Case Rep 14: 543-547, 2013.","DOI":"10.12659\/AJCR.889684"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol 12: 983-997, 2017.","DOI":"10.2215\/CJN.11761116"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 23: 324-332, 2003.","DOI":"10.1016\/S0270-9295(03)00049-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yokoyama H, Taguchi T, Sugiyama H, Sato H. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 16: 557-563, 2012.","DOI":"10.1007\/s10157-012-0593-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Malhotra KP, Chandra A, Rao N, Shukla S, Gupta A. Tuberculosis as a microbiologically proven etiology of membranous nephropathy and interstitial nephritis. Saudi J Kidney Dis Transpl 30: 1447-1449, 2019.","DOI":"10.4103\/1319-2442.275491"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shang MH, Zhu N, Hao J, et al. Membranous nephropathy associated with tuberculosis. Chin Med J (Engl) 129: 622-623, 2016.","DOI":"10.4103\/0366-6999.176986"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chen SJ, Wen YK, Chen ML. Rapidly progressive glomerulonephritis associated with nontuberculous mycobacteria. J Chin Med Assoc 70: 396-399, 2007.","DOI":"10.1016\/S1726-4901(08)70027-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wen YK, Chen ML. Crescentic glomerulonephritis associated with non-tuberculous mycobacteria infection. Ren Fail 30: 339-341, 2008.","DOI":"10.1080\/08860220701861219"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Morimoto K, Hasegawa N, Izumi K, et al. A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013. Ann Am Thorac Soc 14: 49-56, 2017.","DOI":"10.1513\/AnnalsATS.201607-573OC"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Luciano RL, Moeckel GW. Update on the native kidney biopsy: Core Curriculum 2019. Am J Kidney Dis 73: 404-415, 2019.","DOI":"10.1053\/j.ajkd.2018.10.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bobart SA, Han H, Tehranian S, et al. Noninvasive diagnosis of PLA2R-associated membranous nephropathy: a validation study. Clin J Am Soc Nephrol 16: 1833-1839, 2021.","DOI":"10.2215\/CJN.05480421"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yeo MK, Kim YH, Choi DE, Choi SY, Kim KH, Suh KS. The usefulness of phospholipase A2 receptor and IgG4 detection in differentiation primary membranous nephropathy from secondary membranous nephropathy in renal biopsy. Appl Immunohistochem Mol Morphol 26: 591-598, 2018.","DOI":"10.1097\/PAI.0000000000000460"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Radice A, Pieruzzi F, Trezzi B, et al. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. J Nephrol 31: 271-278, 2018.","DOI":"10.1007\/s40620-017-0451-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary <i>versus<\/i> secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 26: 709-715, 2013.","DOI":"10.1038\/modpathol.2012.207"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. van de Logt AE, Fresquet M, Wetzels JF, Brenchley P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int 96: 1292-1302, 2019.","DOI":"10.1016\/j.kint.2019.07.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Granata F, Petraroli A, Boilard E, et al. Activation of cytokine production by secreted phospholipase A<sub>2<\/sub> in human lung macrophages expressing the M-type receptor. J Immunol 174: 464-474, 2005.","DOI":"10.4049\/jimmunol.174.1.464"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3: 905-919, 2008.","DOI":"10.2215\/CJN.04321007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shiiki H, Saito T, Nishitani Y, et al.; Members and Coworkers of the Research Group on Progressive Renal Diseases in Japan. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 65: 1400-1407, 2004.","DOI":"10.1111\/j.1523-1755.2004.00518.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320: 210-215, 1989.","DOI":"10.1056\/NEJM198901263200403"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cameron JS, Healy MJ, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med 74: 133-156, 1990.","DOI":"10.1093\/oxfordjournals.qjmed.a068422"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sims S, Rotellar C. Therapy of membranous nephropathy: use of low-protein diet. J Am Soc Nephrol 6: 136-137, 1995.","DOI":"10.1681\/ASN.V61136"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schieppati A, Ruggenenti P, Perna A, Remuzzi G. Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol 23: 333-339, 2003.","DOI":"10.1016\/S0270-9295(03)00050-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int 66: 1199-1205, 2004.","DOI":"10.1111\/j.1523-1755.2004.00873.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hofstra JM, Fervenza FC, Wetzels JF. Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol 9: 443-458, 2013.","DOI":"10.1038\/nrneph.2013.125"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cattran DC, Reich HN, Kim SJ, Troyanov S. Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin J Am Soc Nephrol 6: 1591-1598, 2011.","DOI":"10.2215\/CJN.11001210"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline. Clin Infect Dis 71: 905-913, 2020.","DOI":"10.1093\/cid\/ciaa1125"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, et al.; the DAPA-CKD Trial Committees and Investigators. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383: 1436-1446, 2020.","DOI":"10.1056\/NEJMoa2024816"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Cherney DZI, Dekkers CCJ, Barbour SJ, et al.; DIAMOND investigators. Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial. Lancet Diabetes Endocrinol 8: 582-593, 2020.","DOI":"10.1016\/S2213-8587(20)30162-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5527-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:33:24Z","timestamp":1768620804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5527-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5527-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5527-25"}}